The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-2-[(biphenyl-4-ylsulfonyl)amino]-5-(propylamino)-5-oxopentanoic acid ID: ALA3827306
PubChem CID: 127044139
Max Phase: Preclinical
Molecular Formula: C20H24N2O5S
Molecular Weight: 404.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCNC(=O)CC[C@H](NS(=O)(=O)c1ccc(-c2ccccc2)cc1)C(=O)O
Standard InChI: InChI=1S/C20H24N2O5S/c1-2-14-21-19(23)13-12-18(20(24)25)22-28(26,27)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h3-11,18,22H,2,12-14H2,1H3,(H,21,23)(H,24,25)/t18-/m0/s1
Standard InChI Key: NGVKQXNJLILPFW-SFHVURJKSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
-5.1975 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8995 3.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9005 5.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2002 6.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2012 7.5037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1954 1.7981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.2380 3.5960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1621 8.1040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5998 3.0012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5009 8.2541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 2.0999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6378 0.9001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.5019 9.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8017 10.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8024 11.7053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 6 2 0
1 7 1 0
5 8 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
11 17 1 0
10 14 1 0
9 10 1 0
2 9 1 6
5 23 1 0
10 24 2 0
10 25 2 0
23 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.49Molecular Weight (Monoisotopic): 404.1406AlogP: 2.39#Rotatable Bonds: 10Polar Surface Area: 112.57Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.44CX Basic pKa: ┄CX LogP: 2.44CX LogD: -0.95Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: -0.86
References 1. Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.. (2016) Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays., 24 (18): [PMID:27452283 ] [10.1016/j.bmc.2016.07.023 ]